Making Millennial Medicine More Meta

ABSTRACT Although the importance of human genetic polymorphisms in therapeutic outcomes is well established, the role of specific genotypic or copy number variants in our “second genome” (the microbiome) has been largely overlooked. In this Perspective, I will discuss three major barriers to integra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Peter J. Turnbaugh
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/f327593d047b478881c6c38faa387c58
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f327593d047b478881c6c38faa387c58
record_format dspace
spelling oai:doaj.org-article:f327593d047b478881c6c38faa387c582021-12-02T18:15:47ZMaking Millennial Medicine More Meta10.1128/mSystems.00154-172379-5077https://doaj.org/article/f327593d047b478881c6c38faa387c582018-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00154-17https://doaj.org/toc/2379-5077ABSTRACT Although the importance of human genetic polymorphisms in therapeutic outcomes is well established, the role of specific genotypic or copy number variants in our “second genome” (the microbiome) has been largely overlooked. In this Perspective, I will discuss three major barriers to integrating metagenomics into pharmacology, highlighting ongoing research by us and others that has begun to shed light on the mechanisms that link the human microbiome to the efficacy and toxicity of small-molecule and biological therapies. The challenges for the next 5 years and beyond are many, requiring interdisciplinary scientific teams working at the interface of chemistry and biology, and a consideration of far more variables than traditionally included in pharmacological modeling. However, the potential benefits are immense. Continued progress could enable more precise tools for predicting patient responses and the development of a new generation of therapeutics based on, or targeted at, the human microbiome.Peter J. TurnbaughAmerican Society for Microbiologyarticlechemical biologymetagenomicsmicrobiomepharmacologyprecision medicinetoxicologyMicrobiologyQR1-502ENmSystems, Vol 3, Iss 2 (2018)
institution DOAJ
collection DOAJ
language EN
topic chemical biology
metagenomics
microbiome
pharmacology
precision medicine
toxicology
Microbiology
QR1-502
spellingShingle chemical biology
metagenomics
microbiome
pharmacology
precision medicine
toxicology
Microbiology
QR1-502
Peter J. Turnbaugh
Making Millennial Medicine More Meta
description ABSTRACT Although the importance of human genetic polymorphisms in therapeutic outcomes is well established, the role of specific genotypic or copy number variants in our “second genome” (the microbiome) has been largely overlooked. In this Perspective, I will discuss three major barriers to integrating metagenomics into pharmacology, highlighting ongoing research by us and others that has begun to shed light on the mechanisms that link the human microbiome to the efficacy and toxicity of small-molecule and biological therapies. The challenges for the next 5 years and beyond are many, requiring interdisciplinary scientific teams working at the interface of chemistry and biology, and a consideration of far more variables than traditionally included in pharmacological modeling. However, the potential benefits are immense. Continued progress could enable more precise tools for predicting patient responses and the development of a new generation of therapeutics based on, or targeted at, the human microbiome.
format article
author Peter J. Turnbaugh
author_facet Peter J. Turnbaugh
author_sort Peter J. Turnbaugh
title Making Millennial Medicine More Meta
title_short Making Millennial Medicine More Meta
title_full Making Millennial Medicine More Meta
title_fullStr Making Millennial Medicine More Meta
title_full_unstemmed Making Millennial Medicine More Meta
title_sort making millennial medicine more meta
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/f327593d047b478881c6c38faa387c58
work_keys_str_mv AT peterjturnbaugh makingmillennialmedicinemoremeta
_version_ 1718378369424293888